Compounds > mitomycin
Page last updated: 2024-08-16

mitomycin and vitamin k 3

mitomycin has been researched along with vitamin k 3 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Deschl, U; Platz, SJ; Schleger, C1
Celli, CM; Jaiswal, AK; Knox, R; Tran, N1
Hatta, T; Higashi, N; Hirai, K; Ishigaki, Y; Shimada, H; Simamura, E1
Adachi, N; Grúz, P; Honma, M; Kanemaru, Y; Matsumoto, K; Niimi, N; Nohmi, T; Suzuki, T1

Other Studies

6 other study(ies) available for mitomycin and vitamin k 3

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Development of an in vitro model for vascular injury with human endothelial cells.
    ALTEX, 2004, Volume: 21 Suppl 3

    Topics: 3T3 Cells; Amrinone; Animal Testing Alternatives; Animals; Antibiotics, Antineoplastic; Antifibrinolytic Agents; Cell Membrane Permeability; Cell Survival; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Electric Impedance; Endothelial Cells; Endothelium, Vascular; Epoprostenol; Humans; Immunosuppressive Agents; Injections, Intravenous; Mice; Mitomycin; Models, Biological; Phosphodiesterase Inhibitors; Rolipram; Thromboxane A2; Umbilical Veins; Vitamin K 3

2004
NRH:quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs.
    Biochemical pharmacology, 2006, Jul-28, Volume: 72, Issue:3

    Topics: Animals; Antineoplastic Agents; Aziridines; Benzopyrenes; Biotransformation; Cell Survival; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Cross-Linking Reagents; DNA, Complementary; Dose-Response Relationship, Drug; Hydroquinones; Indolequinones; Keratinocytes; Mice; Mice, Knockout; Mitomycin; Mitomycins; Quinone Reductases; Quinones; Transfection; Vitamin K 3

2006
Bioreductive activation of quinone antitumor drugs by mitochondrial voltage-dependent anion channel 1.
    Anatomical science international, 2008, Volume: 83, Issue:4

    Topics: Antineoplastic Agents; Apoptosis; Cell Line; Doxorubicin; HeLa Cells; Humans; Hydrogen Peroxide; Mitochondria; Mitomycin; NAD; Naphthoquinones; Oxidation-Reduction; Quinones; Vitamin K 3; Voltage-Dependent Anion Channel 1

2008
Catalytic and non-catalytic roles of DNA polymerase κ in the protection of human cells against genotoxic stresses.
    Environmental and molecular mutagenesis, 2015, Volume: 56, Issue:8

    Topics: Benzo(a)pyrene; Cell Line; Cell Survival; DNA Damage; DNA-Directed DNA Polymerase; Genetic Complementation Test; Humans; Hydrogen Peroxide; Methyl Methanesulfonate; Mitomycin; Mutagens; Ultraviolet Rays; Vitamin K 3

2015